sincalide has been researched along with Carcinoma-256--Walker* in 1 studies
1 other study(ies) available for sincalide and Carcinoma-256--Walker
Article | Year |
---|---|
Facilitation of cancer-associated anorexia by cholecystokinin.
Cholecystokinin octapeptide (CCK-8, 5 micrograms/kg) was injected i.p. into male Sprague-Dawley rats bearing the Walker 256-carcinosarcoma, or into non-tumour bearing controls, on a 20-h food deprivation schedule. Food and water intake and body weight maintenance were monitored for 15 days after tumour implantation and compared to that of tumour-bearing animals not injected with CCK-8. Food intake was significantly reduced for the duration of the two 4-day periods of CCK-8 injection, indicating that behavioural tolerance to this peptide did not occur. The severity of anorexia and body weight loss in tumour-bearing animals was significantly greater than that observed in non-tumour bearing controls, for the first 13 days of observation. These results indicate that endogenous peptides, such as CCK, may function in tumour-bearing animals to enhance the anorexia and wasting which typifies the anorexia cachexia syndrome. Topics: Animals; Anorexia; Body Weight; Cachexia; Carcinoma 256, Walker; Drinking; Eating; Feeding and Eating Disorders; Male; Rats; Rats, Inbred Strains; Satiation; Sincalide | 1988 |